Follow this preprint
Suboptimal SARS-CoV-2-specific CD8+ T-cell response associated with the prominent HLA-A*02:01 phenotype
Jennifer R Habel, Thi H O Nguyen, Carolien E van de Sandt, Jennifer A Juno, Priyanka Chaurasia, Kathleen Wragg, Marios Koutsakos, Luca Hensen, Xiaoxiao Jia, Brendon Chua, Wuji Zhang, Hyon-Xhi Tan, Katie L Flanagan, Denise L Doolan, Joseph Torresi, Weisan Chen, Linda M Wakim, Allen C Cheng, Peter C Doherty, Jan Petersen, Jamie Rossjohn, Adam K Wheatley, Stephen J Kent, Louise C Rowntree, Katherine Kedzierska
doi: https://doi.org/10.1101/2020.08.17.20176370
Now published in Proceedings of the National Academy of Sciences doi: 10.1073/pnas.2015486117
Jennifer R Habel
1Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia;
Thi H O Nguyen
1Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia;
Carolien E van de Sandt
1Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia;
2Department of Hematopoiesis, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands;
Jennifer A Juno
1Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia;
Priyanka Chaurasia
3Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia;
Kathleen Wragg
1Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia;
Marios Koutsakos
1Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia;
Luca Hensen
1Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia;
Xiaoxiao Jia
1Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia;
Brendon Chua
1Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia;
Wuji Zhang
1Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia;
Hyon-Xhi Tan
1Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia;
Katie L Flanagan
4Department of Infectious Diseases, Launceston General Hospital, Launceston, Tasmania, Australia;
5School of Health Sciences and School of Medicine, University of Tasmania, Launceston, Tasmania, Australia;
6Department of Immunology and Pathology, Monash University, Commercial Road, Melbourne, Victoria, Australia;
7School of Health and Biomedical Science, RMIT University, Melbourne, Victoria, Australia;
Denise L Doolan
8Centre for Molecular Therapeutics, Australian Institute of Tropical Health & Medicine, James Cook University, Cairns, Queensland, Australia;
Joseph Torresi
1Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia;
Weisan Chen
9Department of Biochemistry and Genetics, La Trobe Institute of Molecular Science, La Trobe University, Bundoora 3084, Victoria, Australia;
Linda M Wakim
1Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia;
Allen C Cheng
10School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia;
11Infection Prevention and Healthcare Epidemiology Unit, Alfred Health, Melbourne, Victoria, Australia;
Peter C Doherty
1Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia;
12Department of Immunology, St Jude Children’s Research Hospital, Memphis, TN 38105, USA;
Jan Petersen
3Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia;
13Australian Research Council Centre of Excellence for Advanced Molecular Imaging, Monash University, Clayton 3800, Victoria, Australia;
Jamie Rossjohn
3Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia;
13Australian Research Council Centre of Excellence for Advanced Molecular Imaging, Monash University, Clayton 3800, Victoria, Australia;
14Institute of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, United Kingdom;
Adam K Wheatley
1Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia;
15ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, University of Melbourne, Melbourne, Victoria, Australia;
Stephen J Kent
1Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia;
15ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, University of Melbourne, Melbourne, Victoria, Australia;
Louise C Rowntree
1Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia;
Katherine Kedzierska
1Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia;

Data Availability
All the data are available upon request
Posted August 19, 2020.
Suboptimal SARS-CoV-2-specific CD8+ T-cell response associated with the prominent HLA-A*02:01 phenotype
Jennifer R Habel, Thi H O Nguyen, Carolien E van de Sandt, Jennifer A Juno, Priyanka Chaurasia, Kathleen Wragg, Marios Koutsakos, Luca Hensen, Xiaoxiao Jia, Brendon Chua, Wuji Zhang, Hyon-Xhi Tan, Katie L Flanagan, Denise L Doolan, Joseph Torresi, Weisan Chen, Linda M Wakim, Allen C Cheng, Peter C Doherty, Jan Petersen, Jamie Rossjohn, Adam K Wheatley, Stephen J Kent, Louise C Rowntree, Katherine Kedzierska
medRxiv 2020.08.17.20176370; doi: https://doi.org/10.1101/2020.08.17.20176370
Now published in Proceedings of the National Academy of Sciences doi: 10.1073/pnas.2015486117
Subject Area
Reviews and Context
1
Comment
0
TRIP Peer Reviews
2
Community Reviews
0
Automated Services
1
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (413)
- Allergy and Immunology (734)
- Anesthesia (215)
- Cardiovascular Medicine (3142)
- Dermatology (267)
- Emergency Medicine (467)
- Epidemiology (13106)
- Forensic Medicine (15)
- Gastroenterology (873)
- Genetic and Genomic Medicine (4923)
- Geriatric Medicine (453)
- Health Economics (758)
- Health Informatics (3104)
- Health Policy (1110)
- Hematology (414)
- HIV/AIDS (978)
- Medical Education (459)
- Medical Ethics (121)
- Nephrology (507)
- Neurology (4684)
- Nursing (248)
- Nutrition (692)
- Oncology (2414)
- Ophthalmology (688)
- Orthopedics (270)
- Otolaryngology (334)
- Pain Medicine (313)
- Palliative Medicine (88)
- Pathology (522)
- Pediatrics (1254)
- Primary Care Research (526)
- Public and Global Health (7244)
- Radiology and Imaging (1619)
- Respiratory Medicine (949)
- Rheumatology (463)
- Sports Medicine (407)
- Surgery (522)
- Toxicology (65)
- Transplantation (223)
- Urology (193)